Regulatory Authority PharmOut is the largest specialised regulatory company in South East Asia serving pharmaceutical, medical device, veterinary, and herbal medicines including medicinal cannabis, indicating strong potential to cross-sell regulatory affairs, licensing, and compliance services to firms expanding in SEA or seeking COE regulatory support.

Full-Service Partner With capabilities spanning architecture, engineering, GMP training, compliance, pharmacovigilance, and project management aligned to PIC/s, TGA, and FDA standards, target mid-sized manufacturers seeking end-to-end support for new facilities, validation, and ongoing regulatory readiness.

Global Footprint Consultancy offices worldwide and a Melbourne HQ position PharmOut as a gateway for multinational clients needing regional regulatory alignment in Asia-Pacific, offering collaboration opportunities for global pharma to localize regulatory strategies.

Industry Collaboration Recent activity around events like Pharma & Device Forum and partnerships with technology providers (ValGenesis in the past) suggest a strategy to engage prospects through thought leadership and integrated tech-enabled compliance workflows.

Growth Profile Revenue in the lower-mid tens of millions with a workforce of 51-200 indicates room for upsell to larger projects, ongoing GMP training programs, and extended pharmacovigilance services as clients scale manufacturing and regulatory requirements.